Sulfamethizole
![]() | |
| Systematic (IUPAC) name | |
|---|---|
|
4-amino-N-(5-methyl-1,3,4-thiadiazol-2-yl)- benzenesulfonamide | |
| Clinical data | |
| AHFS/Drugs.com | Micromedex Detailed Consumer Information |
| MedlinePlus | a682231 |
| Pharmacokinetic data | |
| Protein binding | 98–99% |
| Biological half-life | 3–8 hours |
| Identifiers | |
| CAS Number |
144-82-1 |
| ATC code | B05CA04 (WHO) D06BA04 J01EB02 S01AB01 QJ01EQ02 |
| PubChem | CID 5328 |
| DrugBank |
DB00576 |
| ChemSpider |
5137 |
| UNII |
25W8454H16 |
| KEGG |
D00870 |
| ChEBI |
CHEBI:9331 |
| ChEMBL |
CHEMBL1191 |
| Chemical data | |
| Formula | C9H10N4O2S2 |
| Molar mass | 270.333 g/mol |
| |
| |
| (verify) | |
Sulfamethizole is a sulfonamide antibiotic.
References
- Ratanajamit C, Skriver M, Nørgaard M, Jepsen P, Schønheyder H, Sørensen H (2003). "Adverse pregnancy outcome in users of sulfamethizole during pregnancy: a population-based observational study.". J Antimicrob Chemother 52 (5): 837–41. doi:10.1093/jac/dkg438. PMID 14519675.
- Kerrn M, Frimodt-Møller N, Espersen F (2003). "Effects of Sulfamethizole and Amdinocillin against Escherichia coli Strains (with Various Susceptibilities) in an Ascending Urinary Tract Infection Mouse Model". Antimicrob Agents Chemother 47 (3): 1002–9. doi:10.1128/AAC.47.3.1002-1009.2003. PMC 149286. PMID 12604534.
- Watanabe H, Hastings J (1990). "Inhibition of bioluminescence in Photobacterium phosphoreum by sulfamethizole and its stimulation by thymine". Biochim Biophys Acta 1017 (3): 229–34. doi:10.1016/0005-2728(90)90189-B. PMID 2372557.
| ||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.
